xu 62-320 has been researched along with (3R,5S)-fluvastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baader, E; Bartmann, W; Beck, G; Bergmann, A; Granzer, E; Jendralla, H; Kesseler, K; Krause, R; Schacht, U; von Kerekjarto, B | 1 |
Connolly, PJ; Loughney, DA; Minor, LK; Westin, CD | 1 |
2 other study(ies) available for xu 62-320 and (3R,5S)-fluvastatin
Article | Year |
---|---|
Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids.
Topics: Animals; Anticholesteremic Agents; Caproates; Carcinoma, Hepatocellular; Cholesterol; Dogs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Liver; Liver Neoplasms; Lovastatin; Male; Molecular Structure; Rabbits; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 1991 |
HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts.
Topics: Acetates; Animals; Carcinoma, Hepatocellular; Cholesterol; Hydroxy Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indazoles; Liver; Liver Neoplasms; Lovastatin; Models, Molecular; Molecular Structure; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 1993 |